Category: Series
-
Today’s idea: Intema Solutions (ITM.V) is building a e-sports platform of e-sports platforms
Word on the street tells me Intema Solutions (ITM.V), which has been trade halted for a few months while the regulators go through their raft of recent transactions, is about to go free trading again any day. To be clear: The stock will drop when it does. That’s no beef against ITM – which is…
-
CEO interview: Intema Solutions’ (ITM.V) boss Laurent Benezra
Canada’s Intema Solutions (ITM.V) is not just an e-sports company. They’re an e-sports company acquiring other e-sports niche companies to put together one larger e-sports community, like a capital markets Transformer. They’re been red hot on the M&A tilt over the last six months and featured a strong stock performance before being trade-halted for a…
-
Flashback: Intema Solutions (ITM.V) makes a big boy move, will acquire Loot.Bet online gaming platform
(First posted May 8, 2021) For the last few months, the conversation around Intema Solutions (ITM.V) has gone something like this: Intema: We bought an online health platform! Market: Meh. We’ll buy a little. Intema: We bought an e-sports tournament platform! Market: Only 50,000 registered users? Huh. We’ll buy a little.. Intema: We bought an…
-
Marvel Discovery (MARV.V) finds visible gold at Blackfly Gold Project
Marvel Discovery (MARV.V) reported progress on the drilling taking place at their Blackfly Gold Project, finding visible gold. Marvel has completed 9 diamond drills completed to date for 1,116.25m; the drilling has been concentrated around the historical shaft area of their project, with 4 holes drilled at the Blackfly Northeast Zone. The historical shaft was…
-
Manganese X (MN.V) advances Battery Hill PEA
Manganese X Energy (MN.V) announced they are completing, together with Kemetco Research, test work for the Preliminary Economic Assessment (PEA) of their Battery Hill project. The Battery Hill project is located in New Brunswick, near the American border, and is one of the largest manganese resources in North America. The project has a measured and…
-
Cybin (CYBN.NE) Closes Overnight Public Offering, Fortifies Cash Balance
Cybin (CYBN.NE) announced today that it has closed its previously announced overnight marketed offering including the exercise in full of the over-allotment option granted to the Underwriters. “Investor demand for this financing was very strong and we are thankful for the outstanding work of our banking syndicate partners and advisors and we welcome all new…
-
Filament Health (FH.NE) is experimenting with mushrooms and compounds far beyond just psilocybin
Mushroom enthusiasts Filament Health (FH.NE) is looking at mushroom compounds far beyond just psilocybin as the company is run by actual mushroom enthusiasts with access to a lot of tools. Filament has the capabilities to experiment and come up with interesting new compounds, extraction methods, and potential future products that probably go far beyond whatever…
-
Buy Robin Hood (HOOD.Q)? Why don’t I just burn my money instead, at least I’ll get the warmth..
Technology has never been able to bring us an accurate means of assessing someone’s intelligence. The IQ test is a loose guide at best, career status can be boosted based on where you got your start in life and how much Great Uncle Cornelius left you, and number of social media followers only generally provides…
-
Cybin (CYBN.NE) gets final approval to list on NYSE American and announces public offering
Cybin (CYBN.NE) announced that they have received final approval from the New York Stock Exchange (NYSE) to list its shares on the NYSE American exchange. Beginning next Thursday, on August 5, 2021, Cybin will begin trading on the NYSE American under the ticker “CYBN”. Cybin will continue to trade on the NEO exchange, also under…
-
Xphyto (XPHY.C) partner/acquisition target achieves major milestone with Covid-19 biosensor candidates
On July 28, 2021 Xphyto Therapeutics (XPHY.C) announced that its acquisition target, 3a-diagnostics GmbH, has identified the first saliva-activated in-mouth biosensor candidates for the detection of a COVID-19 infection. Xphyto Therapeutics is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities. 3a-diagnostics is currently a commercial partner of…